重复经颅磁刺激对多发性硬化患者认知功能 及情绪的影响
Effects of Repetitive Transcranial Magnetic Stimulation on Cognitive Function and Emotion in Patients with Multiple Sclerosis
DOI: 10.12677/acm.2026.1651969, PDF,   
作者: 王鑫鑫:内蒙古科技大学包头医学院,内蒙古 包头;甄 瑾*:内蒙古自治区人民医院神经内科,内蒙古 呼和浩特
关键词: 多发性硬化重复经颅磁刺激认知功能抑郁焦虑Multiple Sclerosis Repetitive Transcranial Magnetic Stimulation Cognitive Function Depression Anxiety
摘要: 目的:探讨高频重复经颅磁刺激(rTMS)对复发缓解型多发性硬化(RRMS)患者认知功能及情绪症状的影响。方法:纳入2024年7月至2025年11月就诊于内蒙古自治区人民医院的RRMS患者37例,均存在认知功能障碍,随机分为实验组(n = 15)和对照组(n = 22)。两组均维持原有疾病修正治疗,实验组加用20 Hz高频rTMS刺激左侧背外侧前额叶皮层(DLPFC),每周5次,连续2周(共10次)。对照组不予特殊干预。于治疗前、治疗后3个月及6个月采用简易精神状态量表(MMSE)、蒙特利尔认知评估量表(MoCA)评估认知功能,采用汉密尔顿抑郁量表(HAMD-17)、汉密尔顿焦虑量表(HAMA-14)评估情绪症状。结果:两组基线各量表评分无显著差异。干预后3个月和6个月,实验组MMSE、MoCA评分均显著高于对照组(P < 0.05),HAMD、HAMA评分均极显著低于对照组(P < 0.001)。重复测量方差分析显示,各量表评分的组别 × 时间交互效应显著(P < 0.01),提示rTMS干预效应独立于时间进程。实验组6个月时各评分较3个月略有回升,但仍显著优于基线及同期对照组,且MoCA评分始终维持正常阈值(>26分)。结论:高频rTMS刺激左侧DLPFC可显著改善RRMS患者的认知功能和情绪症状。
Abstract: Objective: To investigate the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on cognitive function and emotional symptoms in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: A total of 37 RRMS patients admitted to the Inner Mongolia Autonomous Region People’s Hospital from July 2024 to November 2025, all exhibiting cognitive dysfunction, were enrolled and randomly assigned to either the experimental group (n = 15) or the control group (n = 22). Both groups maintained their original disease-modifying therapy; the experimental group additionally received 20 Hz high-frequency rTMS stimulation to the left dorsolateral prefrontal cortex (DLPFC) five times per week for two consecutive weeks (totaling 10 sessions), while the control group received no special intervention. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment Scale (MoCA) before treatment and at 3 and 6 months post-treatment, while emotional symptoms were evaluated using the Hamilton Depression Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA-14). Results: No significant baseline differences were observed between the two groups on any of the scales. At 3 and 6 months post-intervention, the experimental group showed significantly higher MMSE and MoCA scores (P < 0.05) and markedly lower HAMD and HAMA scores (P < 0.001) compared to the control group. Repeated-measurement ANOVA revealed significant interaction effects of group × time on all scales (P < 0.01), indicating that the rTMS intervention effects were independent of time progression. At 6 months, the experimental group exhibited a slight improvement in all scores compared to 3 months, but remained significantly superior to both baseline and the control group at that time, with MoCA scores consistently maintaining normal thresholds (>26 points). Conclusion: High-frequency rTMS stimulation of the left DLPFC significantly improves cognitive function and emotional symptoms in RRMS patients.
文章引用:王鑫鑫, 甄瑾. 重复经颅磁刺激对多发性硬化患者认知功能 及情绪的影响[J]. 临床医学进展, 2026, 16(5): 1668-1675. https://doi.org/10.12677/acm.2026.1651969

参考文献

[1] Zhao, P., Guan, C., Lu, J., Zhang, Y., Wang, B., Huang, L., et al. (2025) Global, Regional, and National Trends and Burden of Multiple Sclerosis in Adolescents and Young Adults: A Data Analysis from 1990 to 2021 and Projections to 2040. Frontiers in Immunology, 16, Article 1685316. [Google Scholar] [CrossRef
[2] 韩金鸣, 宋洋洋. 神经心理学和功能磁共振评估多发性硬化认知功能研究进展[J]. 中风与神经疾病杂志, 2015, 32(7): 667-669.
[3] Hyncicova, E., Kalina, A., Vyhnalek, M., Nikolai, T., Martinkovic, L., Lisy, J., et al. (2018) Health-Related Quality of Life, Neuropsychiatric Symptoms and Structural Brain Changes in Clinically Isolated Syndrome. PLOS ONE, 13, e0200254. [Google Scholar] [CrossRef] [PubMed]
[4] Abualait, T., Mukhtar, S., Murtaza, G., Al-Hussain, F., Ali, E.N. and Bashir, S. (2025) Exploring the Therapeutic and Rehabilitative Role of Transcranial Magnetic Stimulation in Multiple Sclerosis. European Review for Medical and Pharmacological Sciences, 29, 493-506.
[5] Li, J., Kang, W., Wang, X. and Pan, F. (2024) Progress in Treatment of Pathological Neuropathic Pain after Spinal Cord Injury. Frontiers in Neurology, 15, Article 1430288. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, K., Zhou, S., Lu, S., Qin, Y., Li, X., Li, Y., et al. (2025) A Systematic Review of the Efficacy of Repetitive Transcranial Magnetic Stimulation in Treating Dysarthria in Patients with Parkinson’s Disease. Frontiers in Aging Neuroscience, 17, Article 1501640. [Google Scholar] [CrossRef] [PubMed]
[7] Aydin-Abidin, S., Trippe, J., Funke, K., Eysel, U.T. and Benali, A. (2008) High-and Low-Frequency Repetitive Transcranial Magnetic Stimulation Differentially Activates C-Fos and Zif268 Protein Expression in the Rat Brain. Experimental Brain Research, 188, 249-261. [Google Scholar] [CrossRef] [PubMed]
[8] Benster, L., Weissman, C., Suprani, F., et al. (2024) Predictive Modeling of Response to Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression.
[9] Liu, S., Wang, X., Yu, R. and Sun, Y. (2022) Effect of Transcranial Magnetic Stimulation on Treatment Effect and Immune Function. Saudi Journal of Biological Sciences, 29, 379-384. [Google Scholar] [CrossRef] [PubMed]
[10] Rossi, S., Hallett, M., Rossini, P.M. and Pascual-Leone, A. (2009) Safety, Ethical Considerations, and Application Guidelines for the Use of Transcranial Magnetic Stimulation in Clinical Practice and Research. Clinical Neurophysiology, 120, 2008-2039. [Google Scholar] [CrossRef] [PubMed]
[11] O’Reardon, J.P., Solvason, H.B., Janicak, P.G., Sampson, S., Isenberg, K.E., Nahas, Z., et al. (2007) Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biological Psychiatry, 62, 1208-1216. [Google Scholar] [CrossRef] [PubMed]
[12] Maeda, F., Gangitano, M., Thall, M. and Pascual-Leone, A. (2002) Inter-and Intra-Individual Variability of Paired-Pulse Curves with Transcranial Magnetic Stimulation (TMS). Clinical Neurophysiology, 113, 376-382. [Google Scholar] [CrossRef] [PubMed]
[13] Herwig, U., Fallgatter, A.J., Höppner, J., Eschweiler, G.W., Kron, M., Hajak, G., et al. (2007) Antidepressant Effects of Augmentative Transcranial Magnetic Stimulation: Randomised Multicentre Trial. British Journal of Psychiatry, 191, 441-448. [Google Scholar] [CrossRef] [PubMed]
[14] León Ruiz, M., Sospedra, M., Arce, S., Tejeiro-Martínez, J. and Benito-León, J. (2022) Current Evidence on the Potential Therapeutic Applications of Transcranial Magnetic Stimulation in Multiple Sclerosis: A Systematic Review of the Literature. Neurologia (English Edition), 37, 199-215.
[15] Zuo, C., Cao, H., Feng, F., Li, G., Huang, Y., Zhu, L., et al. (2022) Repetitive Transcranial Magnetic Stimulation Exerts Anti-Inflammatory Effects via Modulating Glial Activation in Mice with Chronic Unpredictable Mild Stress-Induced Depression. International Immunopharmacology, 109, Article 108788. [Google Scholar] [CrossRef] [PubMed]
[16] Claverie, D., Cressant, A., Thomasson, J., et al. (2024) rTMS Mechanisms for Posttraumatic Stress Disorder Treatment in a Mouse Model. Journal of Psychiatric Research, 179, 33-43. [Google Scholar] [CrossRef] [PubMed]
[17] Sullivan, A.B., Davis, B., Kidd, J. and Chiong-Rivero, H. (2025) Understanding Depression in People Living with Multiple Sclerosis: A Narrative Review of Recent Literature. Neurology and Therapy, 14, 681-710. [Google Scholar] [CrossRef] [PubMed]
[18] Ahmadpanah, M., Amini, S., Mazdeh, M., Haghighi, M., Soltanian, A., Jahangard, L., et al. (2023) Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) Add-On Therapy to a Standard Treatment in Individuals with Multiple Sclerosis and Concomitant Symptoms of Depression—Results from a Randomized Clinical Trial and Pilot Study. Journal of Clinical Medicine, 12, Article 2525. [Google Scholar] [CrossRef] [PubMed]
[19] Ørbo, M.C., Høier, S., Vangberg, T.R., Csifcsak, G., Grønli, O.K. and Aslaksen, P.M. (2024) The Cerebral and Cognitive Changes after Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression: Study Protocol for a Randomized Double-Blind Sham-Controlled Trial. Trials, 25, Article No. 752. [Google Scholar] [CrossRef] [PubMed]
[20] Christensen, M., Canellas, F., Loft, H. and Montejo, Á. (2024) Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study. Neuropsychiatric Disease and Treatment, 20, 1475-1489. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, C., Gui, J. and Ma, Y. (2025) Interdisciplinary Intervention to Improve Mental Health and Academic Adaptation of Adolescents with Chronic Diseases: Integration of Educational Psychology and Public Health. Frontiers in Psychology, 16, Article 1732927. [Google Scholar] [CrossRef
[22] Patel, M., Teferi, M., Gura, H., et al. (2024) Interleaved TMS/fMRI Shows That Threat Decreases dlPFC-Mediated Top-Down Regulation of Emotion Processing. NPP—Digital Psychiatry and Neuroscience, 2, Article No. 6. [Google Scholar] [CrossRef
[23] Colucci-D’Amato, L., Speranza, L. and Volpicelli, F. (2020) Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. International Journal of Molecular Sciences, 21, Article 7777. [Google Scholar] [CrossRef] [PubMed]
[24] Xu, H., Gu, L., Zhang, S., Wu, Y., Wei, X., Wang, C., et al. (2022) N200 and P300 Component Changes in Parkinson’s Disease: A Meta-Analysis. Neurological Sciences, 43, 6719-6730. [Google Scholar] [CrossRef] [PubMed]